Genmab — Februar 2019

[Vester]

@Bulder har du stillet spm til Winkel ang dette?

[E_L]

preliminary completion dates for Columba and MMY2040 are very similar, even though the latter started later

[E_L]

and we have been told a few times 'recruitment is going very fast'

[Bulder]

yes, I have a Q about this.

[E_L]

@Vester , this is what Jan said last Feb Q&A: Q: In january you started a “Study to evaluate Subcutaneous Daratumumab in
combination with Standard Multiple Myeloma Treatment Regimens”, which is a Phase
2. You already have the Phase 3 SC vs IV study; could these 2 clinical trials be the
basis for an overall approval of SC in all lines and settings?
Jan Van de Winkel: This is a good thought.

[E_L]

@Hen do you know if they changed their target price?

[Hen]

@
EL. Nej, desværre ikke.

[Sibelius]

Ser lige at Genmab havde 20 års fødselsdag forleden. Bekræfter det gamle mundheld om at selv de grimmeste børn kan komme til at se godt ud fuldt udvoksede:-)

[Vester]

thanks El, primary completion date for MMY2040 is even set to a month sooner than Columba.. Maybe that data will come sooner than expected as well

[henrik48]

@Hen...har de “hævet” til underperform eller outperform ?

[henrik48]

Undskyld...jeg har læst det forkert...beklager !

[Helge_LarsenPI-redaktør]

Hans-Henrik om Genmab: http://www.proinvestor.com/debat/76737

[Helge_LarsenPI-redaktør]

12-13 minutter inde i udsendelsen.

[polle1]

Tjaarh, han er ikke sådan rigtig "lun" endnu den gode Hans Henrik

[polle1]

Hov, der røg mit plus, jeg får lige
lavet en donation, Helge

[Helge_LarsenPI-redaktør]

Hans-Henrik overholder sin strategi. Det er fair nok. PS: Kan afsløre at han hungrer efter købssignalet efter brud
af 1.200.

[Helge_LarsenPI-redaktør]

[peter12]

Den norske oliefond har øget ca 0,5% procent i Genmab i 2018 (hvis jeg husker ret) ? https://www.nbim.no/en/the-fund/holdings/holdings-as-at-31.12.2018/?fullsize=true

[polle1]

Så er der doneret, Helge, håber at få mit plus tilbage, det er sgu' så "nøgent" ud uden det

[polle1]

ser